News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,594 Results
Type
Article (40174)
Company Profile (274)
Press Release (659146)
Section
Business (205582)
Career Advice (2033)
Deals (35619)
Drug Delivery (97)
Drug Development (81434)
Employer Resources (171)
FDA (16204)
Job Trends (14910)
News (347478)
Policy (33118)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2580)
Accelerated approval (2)
Adcomms (20)
Allergies (79)
Alliances (49863)
ALS (75)
Alzheimer's disease (1340)
Antibody-drug conjugate (ADC) (102)
Approvals (16189)
Artificial intelligence (212)
Autoimmune disease (11)
Automation (14)
Bankruptcy (359)
Best Places to Work (11682)
BIOSECURE Act (19)
Biosimilars (94)
Biotechnology (193)
Bladder cancer (51)
Brain cancer (24)
Breast cancer (238)
Cancer (1829)
Cardiovascular disease (137)
Career advice (1696)
Career pathing (28)
CAR-T (133)
Cell therapy (380)
Cervical cancer (13)
Clinical research (65752)
Collaboration (720)
Compensation (415)
Complete response letters (18)
COVID-19 (2616)
CRISPR (34)
C-suite (186)
Cystic fibrosis (97)
Data (1765)
Decentralized trials (2)
Denatured (16)
Depression (37)
Diabetes (229)
Diagnostics (6344)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (106)
Drug pricing (96)
Drug shortages (26)
Duchenne muscular dystrophy (69)
Earnings (86059)
Editorial (31)
Employer branding (21)
Employer resources (147)
Events (112349)
Executive appointments (604)
FDA (17197)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (642)
Gene editing (92)
Generative AI (18)
Gene therapy (262)
GLP-1 (669)
Government (4665)
Grass and pollen (4)
Guidances (46)
Healthcare (18938)
Huntington's disease (23)
IgA nephropathy (19)
Immunology and inflammation (94)
Indications (23)
Infectious disease (2738)
Inflammatory bowel disease (132)
Inflation Reduction Act (10)
Influenza (43)
Intellectual property (72)
Interviews (313)
IPO (16535)
IRA (42)
Job creations (3666)
Job search strategy (1446)
Kidney cancer (9)
Labor market (29)
Layoffs (448)
Leadership (14)
Legal (7998)
Liver cancer (70)
Lung cancer (267)
Lymphoma (122)
Machine learning (2)
Management (59)
Manufacturing (252)
MASH (57)
Medical device (13319)
Medtech (13324)
Mergers & acquisitions (19506)
Metabolic disorders (592)
Multiple sclerosis (60)
NASH (16)
Neurodegenerative disease (73)
Neuropsychiatric disorders (24)
Neuroscience (1779)
NextGen: Class of 2025 (6559)
Non-profit (4514)
Northern California (2254)
Now hiring (36)
Obesity (323)
Opinion (203)
Ovarian cancer (61)
Pain (72)
Pancreatic cancer (71)
Parkinson's disease (121)
Partnered (17)
Patents (184)
Patient recruitment (83)
Peanut (46)
People (57499)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20511)
Phase II (28963)
Phase III (21564)
Pipeline (826)
Podcasts (44)
Policy (105)
Postmarket research (2568)
Preclinical (8661)
Press Release (64)
Prostate cancer (86)
Psychedelics (30)
Radiopharmaceuticals (243)
Rare diseases (343)
Real estate (5970)
Recruiting (65)
Regulatory (22278)
Reports (43)
Research institute (2338)
Resumes & cover letters (350)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (60)
Series A (115)
Series B (68)
Service/supplier (13)
Sickle cell disease (49)
Southern California (1946)
Special edition (14)
Sponsored (28)
Startups (3641)
State (2)
Stomach cancer (12)
Supply chain (57)
The Weekly (27)
United States (19854)
Vaccines (640)
Venture capitalists (35)
Webinars (12)
Weight loss (220)
Women's health (30)
Worklife (14)
Date
Today (84)
Last 7 days (613)
Last 30 days (2883)
Last 365 days (34244)
2025 (6184)
2024 (35420)
2023 (40286)
2022 (51385)
2021 (55966)
2020 (54317)
2019 (46944)
2018 (35365)
2017 (32334)
2016 (31747)
2015 (37798)
2014 (31541)
2013 (26605)
2012 (28833)
2011 (29522)
2010 (27594)
Location
Africa (724)
Alabama (48)
Alaska (7)
Arizona (214)
Arkansas (12)
Asia (38024)
Australia (6216)
California (5161)
Canada (1793)
China (423)
Colorado (236)
Connecticut (247)
Delaware (115)
Europe (81614)
Florida (760)
Georgia (177)
Idaho (58)
Illinois (472)
India (23)
Indiana (280)
Iowa (7)
Japan (129)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (787)
Massachusetts (3913)
Michigan (205)
Minnesota (349)
Mississippi (2)
Missouri (72)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (61)
New Jersey (1462)
New Mexico (27)
New York (1472)
North Carolina (883)
North Dakota (7)
Northern California (2254)
Ohio (182)
Oklahoma (13)
Oregon (33)
Pennsylvania (1167)
Puerto Rico (6)
Rhode Island (24)
South America (1100)
South Carolina (15)
South Dakota (1)
Southern California (1946)
Tennessee (85)
Texas (763)
Utah (156)
Virginia (121)
Washington D.C. (57)
Washington State (491)
West Virginia (3)
Wisconsin (44)
699,594 Results for "cn biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Andelyn Biosciences Expands AAV Curator™ Platform Offering to Include Stanton Lab CNS Capsids through a License Agreement from the Broad Institute of MIT and Harvard
February 19, 2025
·
3 min read
Press Releases
CNS Pharmaceuticals, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
February 19, 2025
·
3 min read
Deals
Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets
Harmony Biosciences, announced the acquisition of Epygenix Therapeutics, Inc., accelerating its growth strategy by adding a rare epilepsy franchise to its expanding late-stage pipeline of innovative CNS assets.
April 30, 2024
·
9 min read
Press Releases
Dyne Therapeutics to Present at Stifel 2025 Virtual CNS Forum
March 11, 2025
·
1 min read
Press Releases
CNS Pharmaceuticals Announces Reverse Stock Split
February 19, 2025
·
4 min read
Press Releases
Vistagen to Participate in Stifel 2025 Virtual CNS Forum
March 4, 2025
·
1 min read
Press Releases
Compass Pathways to Participate in Stifel Virtual CNS Forum
March 11, 2025
·
1 min read
Press Releases
CNS Pharmaceuticals to Present at the BIO CEO & Investor Conference
February 10, 2025
·
2 min read
Press Releases
CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing
February 27, 2025
·
4 min read
Drug Development
Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, announced positive preclinical data for its CNS-penetrant NLRP3 inhibitor VTX3232 in murine diet-induced obesity models.
June 5, 2024
·
5 min read
1 of 69,960
Next
